High CTC levels predicted poor outcome in metastatic breast cancer

A high level of circulating tumor cells (CTCs) -- cells that have detached from a tumor and are circulating in the body through the blood -- are an independent prognostic marker in metastatic breast cancer as first-line therapy. In addition, persistence of high CTC level during therapy was found to be an early marker of poor outcome.

Read the whole article on Science Daily

More from Science Daily